Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royal London Asset Management is one of the UK’s leading fund management companies, managing approximately £170–£173 billion in assets as of late 2024. It is a wholly owned subsidiary of the Royal London Group, the UK’s largest mutual pension and investment provider. RLAM offers active investment management across all major asset classes to a wide range of clients including pension schemes, local authorities, insurance companies, charities, endowments, universities, wealth managers and other financial intermediaries. The company has a strong focus on responsible investing and long-term client relationships[1][2][3][5][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Royal London Asset Management.